Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

Clinical trial NCT05491525 · RECRUITING

Trial details

NCT number: NCT05491525
Sponsor: Urovant Sciences GmbH
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Neurogenic Detrusor Overactivity

Start date: 2022-10-12
Primary completion: 2030-03-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.